CARPL.ai has raised $10 million in Series A funding, led by the International Finance Corporation (IFC). The healthtech startup will use the capital to enhance its AI-powered medical imaging platform and expand globally.
TL;DR
- CARPL.ai secures $10M Series A funding led by IFC to scale its AI radiology platform.
- The company will enhance its technology infrastructure and expand its global sales and delivery teams.
- CARPL.ai's AI marketplace hosts over 300 medical imaging AI applications from more than 100 global vendors.
What happened
Healthtech startup CARPL.ai has raised $10 million in a Series A funding round, with the International Finance Corporation (IFC) leading the investment. Existing investor Stellaris Venture Partners and other undisclosed investors also participated in the round. This follows a $6 million funding round in 2023, backed by Stellaris Venture Partners and a group of angel investors.
According to the company, the fresh capital will be used to enhance its technology infrastructure, accelerate product development, and expand its global sales and delivery teams. These efforts aim to meet the growing demand for AI-powered radiology solutions.
Why it matters
CARPL.ai's AI-powered platform enables hospitals and radiologists to manage multiple medical imaging AI applications through a single interface. This unified approach simplifies the integration and management of diagnostic AI tools, reducing the need for multiple standalone platforms.
The company's AI marketplace currently hosts over 300 medical imaging AI applications from more than 100 global vendors. This extensive marketplace allows healthcare providers to access a wide range of diagnostic AI tools, enhancing their capabilities and efficiency.
With the new funding, CARPL.ai aims to further expand its global reach, onboard additional AI applications and healthcare providers, and strengthen its position in the rapidly growing medical imaging AI market.
Key facts
- CARPL.ai raised $10 million in Series A funding led by IFC.
- The company previously raised $6 million in 2023.
- CARPL.ai's AI marketplace hosts over 300 medical imaging AI applications from more than 100 global vendors.
- The company serves 30 hospitals and medical centers across multiple continents.
- Prominent customers include the Singapore Government, RadNet, I-MED Radiology, Fleury, Medica, and the Clinton Health Access Initiative (CHAI) in India.
- Founded in 2018 by Vidur Mahajan, CARPL.ai aims to position itself as a unified AI orchestration platform for radiology departments worldwide.
Context
The healthcare industry is increasingly adopting artificial intelligence to improve diagnostic accuracy, streamline clinical workflows, and enhance patient outcomes. CARPL.ai is well-positioned to capitalize on this trend by providing a unified platform for managing AI-powered radiology solutions.
The global medical imaging AI market is rapidly growing, driven by the need for more efficient and accurate diagnostic tools. CARPL.ai's expansion efforts align with this market growth, as the company seeks to onboard additional AI applications and healthcare providers.
As healthcare providers continue to integrate AI into their operations, platforms like CARPL.ai's will play a crucial role in simplifying the management and deployment of these advanced technologies.